High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment

Background: Patients with microscopic colitis (MC) often present with abdominal pain and diarrhoea, and previous data suggest that there may be overlap between MC and irritable bowel syndrome (IBS). We evaluated the prevalence of IBS-type symptoms in patients with MC, and assess the impact of these...

Full description

Bibliographic Details
Main Authors: John S. Kane, Andrew J. Irvine, Yannick Derwa, Olorunda Rotimi, Alexander C. Ford
Format: Article
Language:English
Published: SAGE Publishing 2018-06-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284818783600
id doaj-1d096bfdb30a4cfb910d2258205f70f7
record_format Article
spelling doaj-1d096bfdb30a4cfb910d2258205f70f72020-11-25T03:34:06ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-28482018-06-011110.1177/1756284818783600High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatmentJohn S. KaneAndrew J. IrvineYannick DerwaOlorunda RotimiAlexander C. FordBackground: Patients with microscopic colitis (MC) often present with abdominal pain and diarrhoea, and previous data suggest that there may be overlap between MC and irritable bowel syndrome (IBS). We evaluated the prevalence of IBS-type symptoms in patients with MC, and assess the impact of these symptoms on psychological health and quality of life. Methods: We conducted a cross-sectional survey of individuals with a histological diagnosis of MC, collecting demographic data, Rome III IBS-type symptoms, and mood, somatization, and quality of life data. Results: In total, 151 (31.6%) of 478 individuals with a new diagnosis of MC completed questionnaires, 52 (34.4%) of whom reported IBS-type symptoms. The commonest histological subtype was collagenous colitis (51.7%, n = 78), followed by lymphocytic colitis (39.1%, n = 59). Individuals with IBS-type symptoms had significantly higher levels of anxiety [Hospital Anxiety and Depression Scale (HADS) anxiety score 8.6 versus 5.1, p < 0.001], depression (HADS depression score 6.2 versus 3.6, p = 0.001), and somatoform-type behaviour (Patient Health Questionnaire 15 score 12.7 versus 8.0, p < 0.001) compared with individuals who did not. Those with IBS-type symptoms scored significantly worse across all domains of the 36-item Short Form questionnaire, except for physical functioning. Conclusions: More than one third of individuals with MC reported IBS-type symptoms, although whether this is due to ongoing inflammation is unclear. These individuals had higher levels of anxiety, depression, and somatization, and impaired quality of life. Identifying concomitant IBS in individuals with MC may have important implications for management decisions.https://doi.org/10.1177/1756284818783600
collection DOAJ
language English
format Article
sources DOAJ
author John S. Kane
Andrew J. Irvine
Yannick Derwa
Olorunda Rotimi
Alexander C. Ford
spellingShingle John S. Kane
Andrew J. Irvine
Yannick Derwa
Olorunda Rotimi
Alexander C. Ford
High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
Therapeutic Advances in Gastroenterology
author_facet John S. Kane
Andrew J. Irvine
Yannick Derwa
Olorunda Rotimi
Alexander C. Ford
author_sort John S. Kane
title High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
title_short High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
title_full High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
title_fullStr High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
title_full_unstemmed High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
title_sort high prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment
publisher SAGE Publishing
series Therapeutic Advances in Gastroenterology
issn 1756-2848
publishDate 2018-06-01
description Background: Patients with microscopic colitis (MC) often present with abdominal pain and diarrhoea, and previous data suggest that there may be overlap between MC and irritable bowel syndrome (IBS). We evaluated the prevalence of IBS-type symptoms in patients with MC, and assess the impact of these symptoms on psychological health and quality of life. Methods: We conducted a cross-sectional survey of individuals with a histological diagnosis of MC, collecting demographic data, Rome III IBS-type symptoms, and mood, somatization, and quality of life data. Results: In total, 151 (31.6%) of 478 individuals with a new diagnosis of MC completed questionnaires, 52 (34.4%) of whom reported IBS-type symptoms. The commonest histological subtype was collagenous colitis (51.7%, n = 78), followed by lymphocytic colitis (39.1%, n = 59). Individuals with IBS-type symptoms had significantly higher levels of anxiety [Hospital Anxiety and Depression Scale (HADS) anxiety score 8.6 versus 5.1, p < 0.001], depression (HADS depression score 6.2 versus 3.6, p = 0.001), and somatoform-type behaviour (Patient Health Questionnaire 15 score 12.7 versus 8.0, p < 0.001) compared with individuals who did not. Those with IBS-type symptoms scored significantly worse across all domains of the 36-item Short Form questionnaire, except for physical functioning. Conclusions: More than one third of individuals with MC reported IBS-type symptoms, although whether this is due to ongoing inflammation is unclear. These individuals had higher levels of anxiety, depression, and somatization, and impaired quality of life. Identifying concomitant IBS in individuals with MC may have important implications for management decisions.
url https://doi.org/10.1177/1756284818783600
work_keys_str_mv AT johnskane highprevalenceofirritablebowelsyndrometypesymptomsinmicroscopiccolitisimplicationsfortreatment
AT andrewjirvine highprevalenceofirritablebowelsyndrometypesymptomsinmicroscopiccolitisimplicationsfortreatment
AT yannickderwa highprevalenceofirritablebowelsyndrometypesymptomsinmicroscopiccolitisimplicationsfortreatment
AT olorundarotimi highprevalenceofirritablebowelsyndrometypesymptomsinmicroscopiccolitisimplicationsfortreatment
AT alexandercford highprevalenceofirritablebowelsyndrometypesymptomsinmicroscopiccolitisimplicationsfortreatment
_version_ 1724560605151494144